New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 6, 2014
11:10 EDTESI, CZR, S, CLNE, ACAS, AEO, MONT, AGNOptions with increasing implied volatility
Options with increasing implied volatility: UVXY ESI CZR S SVXY CLNE ACAS AEO MONT AGN
News For ESI;CZR;S;CLNE;ACAS;AEO;MONT;AGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
October 17, 2014
06:09 EDTCLNEClean Energy initiated with a Hold at MLV & Co.
Target $8.
October 16, 2014
17:10 EDTAEOAbercrombie & Fitch, American Eagle lower after Urban Outfitters warns on sales
Subscribe for More Information
12:42 EDTAGNAckman believes Allergan, Valeant merger likely, CNBC reports
Subscribe for More Information
12:38 EDTAGNAckman says Allergan CEO manipulated Valeant shares, CNBC reports
Subscribe for More Information
08:58 EDTAGNAllergan was pressured by AbbVie news, says BMO Capital
Subscribe for More Information
07:23 EDTAGNIBF Conferences to hold a summit
Ophthalmology Innovation Summit is being held in Chicago on October 16.
October 15, 2014
15:00 EDTAGNShire-Allergan, AbbVie-Pfizer deals possible if merger scrapped, Bloomberg says
Subscribe for More Information
14:10 EDTCZRPennsylvania reports September gaming revenue down 2.2% to $239.5M
Subscribe for More Information
14:06 EDTCZRAtlantic City reports September gaming win down 12.8% to $209.4M
Subscribe for More Information
13:07 EDTAGNAllergan seeing arb-related selling pressure, says BMO Capital
Subscribe for More Information
07:42 EDTMONTMontage Technology reports preliminary Q3 revenue $46M, consensus $43.1M
Montage Technology Group announced preliminary revenue results for Q3 of approximately $46M, exceeding its previously announced guidance range of $41M-$45M. The increased revenue expectations reflect higher sales of its memory interface solutions, which are expected to be approximately $14M or 30% of revenue for Q3, primarily due to increased demand for its DDR4 RDIMM and LRDIMM solutions.
07:07 EDTESIFor profit education positive catalysts outweigh negative, says Wells Fargo
Wells Fargo expects for-profit education stocks to benefit from improved hiring trends and a sale by Corinthian of its assets that, according t othe firm ,would set a valuation floor for the sector. The firm continues to believe that the final gainful employment rule will be neutral to positive for the group. Wells favors the option value on the long side for the sector. Publicly traded companies in the space include American Public Education (APEI), Apollo Education (APOL), Bridgepoint Education (BPI), Career Education (CECO), Corinthian Colleges (COCO), DeVry (DV), Grand Canyon (LOPE), ITT Educational (ESI) and Strayer (STRA).
06:02 EDTCLNEClean Energy delivers 50.6M CNG gallons in Q3
Clean Energy reported it delivered for the first time over 50M compressed natural gas gallons in one quarter. The company plans to grow its CNG sales further with a strategic move to expand its CNG market to large industrial and institutional energy users beyond the nation’s natural gas pipeline by acquiring a controlling interest in NG Advantage, a pioneer in the natural gas “virtual pipeline” delivery system. The NG Advantage investment will primarily be used to fund capital expenditures for expansion and growth in the business. Clean Energy will also purchase NG Advantage’s Milton, Vt., compression station which is on track to supply nearly 16M gasoline-gallon-equivalents of CNG annually. This station will immediately become Clean Energy’s highest-volume station in its nationwide network of almost 500 stations.
October 14, 2014
17:23 EDTESIBarnstar Opportunities reports 5.4% passive stake in ITT Educational
Subscribe for More Information
11:28 EDTCZROptions with increasing implied volatility
Subscribe for More Information
07:54 EDTST-Mobile, Sprint risk turnover courting lower-credit subscribers, WSJ says
Subscribe for More Information
06:03 EDTAGNMarket overreacted to new Irish tax rules, says BMO Capital
BMO Capital believes the market may have overreacted yesterday to the report that Ireland is eliminating the "Double Irish" tax loophole. The firm says Allergan (AGN) confirmed that it incorporated potential changes to Irish tax law in its recently raised earnings guidance while Mallinckrodt (MNK) said it does expect the new tax structure to have an immediate impact. BMO views yesterday's pullback in shares of Allergan, Mallinckrodt and Actavis (ACT) as an overreaction.
October 13, 2014
12:33 EDTCZROptions with increasing implied volatility
Subscribe for More Information
10:06 EDTACASAmerican Capital sells Unwired Holdings to Delphi Automotive for $138M
American Capital (ACAS) announced that its portfolio company Unwired Holdings, parent to Unwired Technology, was sold to Delphi Automotive (DLPH). American Capital and its affiliated fund received $176M in debt and equity proceeds and realized a gain of $70M from the transaction, subject to post-closing adjustments. Of the total proceeds, American Capital received $138M in debt and equity proceeds, realizing a gain of $53M from the transaction, subject to post-closing adjustments. American Capital's compounded annual rate of return earned on its debt and equity securities over the life of its investment was 16%, including interest, dividends, realized gains and fees. American Capital received 2.4 times its equity investment and realized a compounded annual rate of return of 17% over the life of its equity investment, including dividends, realized gains and fees.
06:39 EDTAGNAllergan takeout value at or above $210 per share, says Leerink
Leerink believes Allergan's takeover value is now at or above $210 per share given the company's recent execution. After speaking with management, the firm says Allergan's upside in Q3 was driving by fundamentals, not cost cuts. It continues to view the "most likely and straightforward outcome" for Allergan as being an outright sale of the company. Leerink raised its price target for shares to $215 from $184 and keeps an Outperform rating on Allergan.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use